Chunxing Liu1, Yingying Ding1, Zhen Ning2, Meiyang Gao1, Xing Liu1, Frank Y Wong1, Na He1. 1. Department of Epidemiology, School of Public Health, and the Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai 200032, China. 2. Shanghai Center for Disease Control and Prevention, Shanghai 200336, China.
Abstract
BACKGROUND: Pre-exposure prophylaxis (PrEP) is a biomedical approach for preventing the acquisition of HIV in populations at substantial risk for HIV. However, its uptake among men who have sex with men (MSM) is low in China. The study aimed to identify factors that might influence MSM's uptake and use of PrEP. METHODS: In-depth interviews were conducted with 32 self-identified MSM from a PrEP intervention study evaluating daily oral tenofovir disoproxil fumarate (TDF) to prevent HIV infection. Of these men, 11 were presently using the 'TDF' group; 8 from the 'change-over' group (i.e. initially used PrEP but subsequently quitted); and 13 from the non-user group. Data were analysed using thematic approach. RESULTS: Perception of low HIV risk, mistrust of the national PrEP program, and concerns of side effects were the main reasons for not wanting to use PrEP. Also, lack of main sexual partner's support, difficulties in adhering to the daily TDF regimen, and the inconvenient schedules in securing the medicine were the major reasons for not wanting to use or quitting the use of PrEP. On the other hand, perceived high HIV risk, beliefs in efficacy of PrEP, and worries of transmitting HIV to families were the major motives for PrEP uptake. CONCLUSIONS: Findings suggest that PrEP implementation strategies should first address issues including but not limited to accurate self-assessment of HIV risk, mistrust and limited knowledge about medical trials and PrEP, and ease of accessing PrEP.
BACKGROUND: Pre-exposure prophylaxis (PrEP) is a biomedical approach for preventing the acquisition of HIV in populations at substantial risk for HIV. However, its uptake among men who have sex with men (MSM) is low in China. The study aimed to identify factors that might influence MSM's uptake and use of PrEP. METHODS: In-depth interviews were conducted with 32 self-identified MSM from a PrEP intervention study evaluating daily oral tenofovir disoproxil fumarate (TDF) to prevent HIV infection. Of these men, 11 were presently using the 'TDF' group; 8 from the 'change-over' group (i.e. initially used PrEP but subsequently quitted); and 13 from the non-user group. Data were analysed using thematic approach. RESULTS: Perception of low HIV risk, mistrust of the national PrEP program, and concerns of side effects were the main reasons for not wanting to use PrEP. Also, lack of main sexual partner's support, difficulties in adhering to the daily TDF regimen, and the inconvenient schedules in securing the medicine were the major reasons for not wanting to use or quitting the use of PrEP. On the other hand, perceived high HIV risk, beliefs in efficacy of PrEP, and worries of transmitting HIV to families were the major motives for PrEP uptake. CONCLUSIONS: Findings suggest that PrEP implementation strategies should first address issues including but not limited to accurate self-assessment of HIV risk, mistrust and limited knowledge about medical trials and PrEP, and ease of accessing PrEP.
Authors: Yumeng Wu; Lu Xie; Siyan Meng; Jianhua Hou; Rong Fu; Huang Zheng; Na He; Kathrine Meyers Journal: LGBT Health Date: 2019-06-06 Impact factor: 4.151
Authors: Nioud Mulugeta Gebru; Maria Costanza Benvenuti; Bonnie H P Rowland; Meher Kalkat; Patricia G Chauca; Robert F Leeman Journal: Subst Use Misuse Date: 2022-02-21 Impact factor: 2.362
Authors: Dora Arnold-Forster; Robert Horne; Will Nutland; Sonali Wayal; Michael Rayment; Caroline Rae; Monica Desai; Amanda Clarke; Ann Sullivan; Sheena McCormack; Mitzy Gafos Journal: AIDS Behav Date: 2022-02-19
Authors: Liping Peng; Wangnan Cao; Jing Gu; Chun Hao; Jibin Li; Dannuo Wei; Jinghua Li Journal: Int J Environ Res Public Health Date: 2019-07-23 Impact factor: 3.390